![Ely Benaim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Ely Benaim is Chief Medical Officer bij NovoCure Ltd. In het verleden bekleedde Dr. Benaim de functie van Vice President-Clinical Affairs bij Sangamo Therapeutics, Inc., Chief Medical Officer & SVP-Regulatory Affairs bij Berg Pharma LLC, Senior Director-Clinical Research bij Millennium Pharmaceuticals, Inc., Chief Medical Officer van Rexahn Pharmaceuticals, Inc., Senior Director-Global Oncology bij Salmedix, Inc. en assistent professor aan de Universiteit van Tennessee. Dr. Benaim behaalde een doctoraat aan de Centrale Universiteit van Venezuela.
Eerdere bekende functies van Ely Benaim
| Bedrijven | Functie | Einde |
|---|---|---|
| NOVOCURE LIMITED | Hoofd Techniek/Wetenschap/O&O | 17-01-2023 |
| REXAHN PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 31-03-2019 |
Berg Pharma LLC | Hoofd Techniek/Wetenschap/O&O | 01-01-2015 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Hoofd Techniek/Wetenschap/O&O | 01-01-2013 |
| SANGAMO THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2010 |
Opleiding van Ely Benaim
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
27
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology and small molecule drugs to treat hematologic malignancies | Health Technology |
University of Tennessee
 University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Central University of Venezuela
 Central University of Venezuela Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NovoCure Ltd.
 NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
Berg Pharma LLC |
